← All trials
NCT06308913
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 18, 2024
- Primary completion
- Sep 1, 2026
- Completion date
- Aug 31, 2027
- First posted
- Mar 13, 2024
- Last posted
- Sep 27, 2024
- Enrollment
- 12
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of WisconsinLead sponsor
- National Cancer Institute (NCI)Collaborator
- National Institute of Dental and Craniofacial Research (NIDCR)Collaborator
- University of WisconsinOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.